基因组编辑
计算生物学
数据科学
工程伦理学
医学
计算机科学
基因
遗传学
生物
基因组
工程类
作者
Kelly E. Ormond,Yvonne Bombard,Vence L. Bonham,Lily Hoffman‐Andrews,Heidi Howard,Rosario Isasi,Kiran Musunuru,Kirsten A. Riggan,Marsha Michie,Megan Allyse
出处
期刊:Personalized Medicine
[Future Medicine]
日期:2019-07-01
卷期号:16 (4): 337-350
被引量:30
标识
DOI:10.2217/pme-2018-0155
摘要
Gene-editing techniques have progressed rapidly in the past 5 years. There are already ongoing human somatic gene-editing clinical trials for multiple diseases. And there has been one purported scenario of human germline gene editing in late 2018. In this paper, we will review the current state of the technology, discuss the ethical and social issues that surround the various forms of gene editing, as well as review emerging stakeholder data from professionals, the 'general public' and individuals and families dealing with genetic diseases potentially treatable by gene editing.
科研通智能强力驱动
Strongly Powered by AbleSci AI